Prognostic value of circulating long non-coding RNAs in colorectal cancer patients: a meta-analysis

References

• Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023 May;73(3):233–254. doi: 10.3322/caac.21772
   PubMed Web of Science ®Google Scholar
• Baassiri A, Nassar F, Mukherji D, et al. Exosomal non coding RNA in LIQUID biopsies as a promising biomarker for colorectal cancer. Int J Mol Sci. 2020 Feb 19;21(4):1398. doi: 10.3390/ijms21041398
   PubMed Web of Science ®Google Scholar
• Rao H, Wu H, Huang Q, et al. Clinical value of Serum CEA, CA24-2 and CA19-9 in patients with colorectal cancer. Clin Lab. 2021 Apr 1;67(4). doi: 10.7754/Clin.Lab.2020.200828
   Web of Science ®Google Scholar
• Thomas DS, Fourkala EO, Apostolidou S, et al. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer. 2015 Jul 14;113(2):268–274. doi: 10.1038/bjc.2015.202
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhong J, Zhong B, et al. Exosomes as potential sources of biomarkers in colorectal cancer. Cancer Lett. 2020 Apr 28;476:13–22. doi: 10.1016/j.canlet.2020.01.033
   PubMed Web of Science ®Google Scholar
• Muller D, Gyorffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188722. doi: 10.1016/j.bbcan.2022.188722
   PubMed Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011 Sep 15;25(18):1915–1927. doi: 10.1101/gad.17446611
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRnas in cancer. Nat Med. 2015 Nov;21(11):1253–1261. doi: 10.1038/nm.3981
   PubMed Web of Science ®Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012 Jun;9(6):703–719. doi: 10.4161/rna.20481
   PubMed Web of Science ®Google Scholar
• Xu S, Sui S, Zhang J, et al. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol. 2015;8(5):4881–4891.
   PubMed Web of Science ®Google Scholar
• Cai Q, Wang ZQ, Wang SH, et al. Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathway. Am J Transl Res. 2016;8(10):4068–4081.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yang Y, Wang F, et al. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha. Gut. 2016 Sep;65(9):1494–1504. doi: 10.1136/gutjnl-2014-308392
   PubMed Web of Science ®Google Scholar
• Peng W, Wang Z, Fan H. LncRNA NEAT1 impacts cell proliferation and apoptosis of colorectal cancer via regulation of Akt signaling. Pathol Oncol Res. 2017 Jul;23(3):651–656. doi: 10.1007/s12253-016-0172-4
   PubMed Web of Science ®Google Scholar
• Svoboda M, Slyskova J, Schneiderova M, et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis. 2014 Jul;35(7):1510–1515. doi: 10.1093/carcin/bgu055
   PubMed Web of Science ®Google Scholar
• Li P, Zhang X, Wang H, et al. MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2. Mol Cancer Ther. 2017 Apr;16(4):739–751. doi: 10.1158/1535-7163.MCT-16-0591
   PubMed Web of Science ®Google Scholar
• Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016 May 17;15(1):39. doi: 10.1186/s12943-016-0524-4
   PubMedGoogle Scholar
• Yu S, Wang D, Shao Y, et al. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p. Aging. 2019 Mar 10;11(5):1389–1403. doi: 10.18632/aging.101839
   PubMedGoogle Scholar
• Wu Y, Yang L, Zhao J, et al. Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol Cancer. 2015 Nov 9;14(1):191. doi: 10.1186/s12943-015-0455-5
   PubMedGoogle Scholar
• Fang X, Wang D, Pu K, et al. Diagnostic value of circulating lncRnas as biomarkers of digestive system cancers: a systematic review and meta-analysis. Expert Rev Mol Diagn. 2020 Oct;20(10):1051–1062. doi: 10.1080/14737159.2020.1822169
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010 Sep;25(9):603–605. doi: 10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Gao S, et al. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget. 2016 Dec 20;7(51):85551–85563. doi: 10.18632/oncotarget.13465
   PubMedGoogle Scholar
• Wang R, Du L, Yang X, et al. Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer. J Cancer Res Clin Oncol. 2016 Nov;142(11):2291–2301. doi: 10.1007/s00432-016-2238-9
   PubMed Web of Science ®Google Scholar
• Gong W, Tian M, Qiu H, et al. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma. Cancer Biomark. 2017 Dec 6;20(4):417–424. doi: 10.3233/CBM-170179
   PubMed Web of Science ®Google Scholar
• Shaker OG, Senousy MA, Elbaz EM. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRnas CCAT2 and HULC with colorectal cancer in Egyptian patients. Sci Rep. 2017 Nov 24;7(1):16246. doi: 10.1038/s41598-017-16500-4
   PubMedGoogle Scholar
• Liu L, Meng T, Yang XH, et al. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Cancer Biomark. 2018;22(2):283–299
   PubMed Web of Science ®Google Scholar
• Wang W, Xie Y, Chen F, et al. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World J Gastroenterol. 2019 Aug 7;25(29):3972–3984. doi: 10.3748/wjg.v25.i29.3972
   PubMed Web of Science ®Google Scholar
• Yin H, Hu J, Ye Z, et al. Serum long noncoding RNA NNTAS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR496/RAP2C axis in colorectal cancer. Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12224
   Web of Science ®Google Scholar
• Ye B, Li F, Chen M, et al. A panel of platelet-associated circulating long non-coding RNAs as potential biomarkers for colorectal cancer. Genomics. 2022 Jan;114(1):31–37. doi: 10.1016/j.ygeno.2021.11.026
   PubMed Web of Science ®Google Scholar
• Yin H, Hu J, Ye Z, et al. Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer. Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12224
   Web of Science ®Google Scholar
• Statello L, Guo CJ, Chen LL, et al. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021 Feb;22(2):96–118. doi: 10.1038/s41580-020-00315-9
   PubMed Web of Science ®Google Scholar
• Romero-Barrios N, Legascue MF, Benhamed M, et al. Splicing regulation by long noncoding RNAs. Nucleic Acids Res. 2018 Mar 16;46(5):2169–2184. doi: 10.1093/nar/gky095
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017 Oct 12;36(41):5661–5667. doi: 10.1038/onc.2017.184
   PubMed Web of Science ®Google Scholar
• Tan YT, Lin JF, Li T, et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 2021 Feb;41(2):109–120. doi: 10.1002/cac2.12108
   PubMed Web of Science ®Google Scholar
• Xu Y, Qiu M, Shen M, et al. The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther. 2021 Jul 7;29(7):2209–2218. doi: 10.1016/j.ymthe.2021.03.017
   PubMed Web of Science ®Google Scholar
• Abdi E, Latifi-Navid S. Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer. Pathol Res Pract. 2022 Nov;239:154165. doi: 10.1016/j.prp.2022.154165
   PubMed Web of Science ®Google Scholar
• Zhang D, Du D, Yi S, et al. LncRNA PCAT6: a potential biomarker for diagnosis and prognosis of bladder cancer. Ann Diagn Pathol. 2020 Dec;49:151642.
   PubMed Web of Science ®Google Scholar
• Zeng J, Ma YX, Liu ZH, et al. LncRNA SNHG7 contributes to cell proliferation, invasion and prognosis of cervical cancer. Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9277–9285. doi: 10.26355/eurrev_201911_19420
   PubMed Web of Science ®Google Scholar
• Abdi E, Latifi-Navid S, Latifi-Navid H, et al. LncRNA polymorphisms and upper gastrointestinal cancer risk. Pathol Res Pract. 2021 Feb;218:153324.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Li Y, Ji B, et al. Clinical value of lncRNA LUCAT1 expression in liver cancer and its potential pathways. J Gastrointestin Liver Dis. 2019 Dec 9;28(4):439–447. doi: 10.15403/jgld-356
   PubMed Web of Science ®Google Scholar
• Jiao Y, Li Y, Jia B, et al. The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer. Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20190729
   Google Scholar
• Li X, Yang H, Wang J, et al. High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients. Pathol Res Pract. 2019 Nov;215(11):152638. doi: 10.1016/j.prp.2019.152638
   PubMed Web of Science ®Google Scholar
• Yao XM, Tang JH, Zhu H, et al. High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer. Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5661–5667. doi: 10.26355/eurrev_201712_14010
   PubMed Web of Science ®Google Scholar
• Fang D, Ou X, Sun K, et al. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 2022 Dec;113(12):4135–4150. doi: 10.1111/cas.15581
   PubMed Web of Science ®Google Scholar
• Song J, Chen X, Tian Q, et al. The value of lncRNA GHET1 as a prognostic factor for survival of Chinese cancer outcome: a meta-analysis. Dis Markers. 2019;2019:5824190. doi: 10.1155/2019/5824190
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fan Y, Zhou X, et al. Significance of lncRNA MIR31HG in predicting the prognosis for Chinese patients with cancer: a meta-analysis. Biomarker Med. 2020 Mar;14(4):303–316. doi: 10.2217/bmm-2019-0145
   PubMed Web of Science ®Google Scholar
• Lu H, Liu H, Yang X, et al. LncRNA BLACAT1 May serve as a prognostic predictor in cancer: evidence from a meta-analysis. Biomed Res Int. 2019;2019:1275491. doi: 10.1155/2019/1275491
   PubMed Web of Science ®Google Scholar
• Thin KZ, Tu JC, Raveendran S. Long non-coding SNHG1 in cancer. Clin Chim Acta. 2019 Jul;494:38–47. doi: 10.1016/j.cca.2019.03.002
   PubMed Web of Science ®Google Scholar
• Wang J, Du S, Wang J, et al. The prognostic value of abnormally expressed lncRnas in colorectal cancer: a meta-analysis. PLoS One. 2017;12(6):e0179670
   PubMed Web of Science ®Google Scholar
• Kang W, Zheng Q, Lei J, et al. Prognostic value of long noncoding RNAs in patients with gastrointestinal cancer: a systematic Review and meta-analysis. Dis Markers. 2018;2018:1–15. doi: 10.1155/2018/5340894
   Web of Science ®Google Scholar
• Sole C, Arnaiz E, Manterola L, et al. The circulating transcriptome as a source of cancer liquid biopsy biomarkers. Semin Cancer Biol. 2019 Oct;58:100–108.
   PubMed Web of Science ®Google Scholar
• Li Q, Shao Y, Zhang X, et al. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol. 2015 Mar;36(3):2007–2012. doi: 10.1007/s13277-014-2807-y
   PubMed Web of Science ®Google Scholar
• Viereck J, Thum T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res. 2017 Jan 20;120(2):381–399. doi: 10.1161/CIRCRESAHA.116.308434
   PubMed Web of Science ®Google Scholar
• Molnár B, Galamb O, Kalmár A, et al. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update. Expert Rev Mol Diagn. 2019 Jun;19(6):477–498. doi: 10.1080/14737159.2019.1613891
   PubMed Web of Science ®Google Scholar
• Barwal TS, Sharma U, Vasquez KM, et al. A panel of circulating long non-coding RNAs as liquid biopsy biomarkers for breast and cervical cancers. Biochimie. 2020 Sep;176:62–70.
   PubMed Web of Science ®Google Scholar
• Al Mourgi M, El Askary A, Gharib AF, et al. Circulating long non-coding RNA GAS5: a non-invasive molecular marker for prognosis, response to treatment and survival in non-small cell lung cancer. Cancer Invest. 2021 Jul;39(6–7):505–513. doi: 10.1080/07357907.2021.1928167
   PubMed Web of Science ®Google Scholar